Is Elevance Health Inc (ELV) overvalued? · P/E 18, rev $199.13B
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
This page asks whether Elevance Health Inc (ELV) looks expensive on cached numbers — not a short thesis.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ELV 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ELV stock page for the full model, not this heading.
Not investment advice.